Trading Alert: Biotech Stocks To Watch; (OTCBB: UVFT), (OTCBB: KBLB), (NASDAQ:AMGN), (NYSE:ELN)
Point Roberts, WA - September 24, 2010 (Investorideas.com Newswire) - InvestorIdeas.com, leader in sector research for investors, reports on recent Biotech/ Healthcare Stocks news and trading for September 24th.
Biotech Stocks include UV Flu Technologies, Inc., (OTCBB: UVFT), Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), Amgen Inc. (NASDAQ:AMGM), and Elan Corp. plc (NYSE: ELN)
Sector Snapshot: (Trading at time or release)
UV Flu Technologies, Inc., (OTCBB: UVFT) trading at $ 0.31, up 0.01 (3.33%)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), trading at $ 0. 2145, up 0.0630 (41.58%) on Volume of 20,704,335 shares
Amgen Inc. (NASDAQ:AMGN), trading at $ 56.10, up 0.38 (0.68%)
Elan Corp. plc NYSE:ELN) trading at $ 5.42, up 0.30 (5.86%)
Biotech Stocks to Watch News
UV Flu Technologies, Inc., (OTCBB: UVFT) Key Highlights and Recent Press
UV Flu Technologies, Inc., (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. UV Flu is committed to providing clean air to improve health and prevent the spread of disease.
The company recently announced that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly contagious strains of bacteria such as MRSA, the Company is implementing a national campaign to inform the public how its ViraTech UV-400 indoor air purifier significantly helps reduce exposure risks.
The U.S. CDC has described antibiotic resistance as “one of the world’s most pressing health problems” as “the number of bacteria resistant to antibiotics has increased in the last decade [and] … many bacterial infections are becoming resistant to the most commonly prescribed antibiotic treatments.” The World Health Organization (WHO) has identified antibiotic resistance as “one of the three greatest threats to human health.” Source : http://www.idsociety.org/10x20.htm
“UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) is pleased to announce that the company and its flagship UV-400 air purification system will be featured on a segment of the “Designing Spaces” TV Show, to be aired nationally during the 4th quarter. The show, to be aired on the Women’s Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.”
UV Flu Technologies, Inc., Key Highlights
• FDA Approved as a Class II Medical device
• Extensive testing by EPA and FDA certified laboratories
confirm the proprietary system has over 99% effectiveness of eliminating bacteria
• The Company’s strategic differentiators include excellent independent test
results proving the effectiveness and safety of its products, proprietary design,
and FDA market clearance approving the sale of its products as medical
• The Company has been issued U.S. Patent No. 6939397 with 43 claims covering
its innovative removable cartridge, housing, UV chamber, UV radiation
source and baffle technology.
• UV Flu’s products are environmentally friendly. The energy efficient system
does not use or produce ozone, uses less energy than a 100 watt light bulb
and can qualify for Green Building programs.
• Experts have warned that a new type of drug-resistant superbug is emerging.
NDM-1 is a gene carried by bacteria that makes the strain resistant to some of
the most powerful antibiotics. NDM-1 can easily now jump from one strain of
bacteria to another.
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB)
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) Recent News: “Kraig Biocraft Laboratories, Inc. is very pleased to announce that the University of Notre Dame and Kraig Biocraft Laboratories will hold a joint press conference Wednesday, September 29, 2010 on the Notre Dame campus to describe a new research breakthrough and its possible biomedical and commercial applications.”
Full Article: http://finance.yahoo.com/news/University-of-Notre-Dame-and-iw-1958169015.html?x=0&.v=1
About Kraig Biocraft Laboratories, Inc: is a biotechnology company focused on the development of commercially significant high performance polymers and technical fiber. Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials including spider silk. Our work is focused on the development of spider silk and other high strength polymers that we believe have the potential for significant industrial and consumer applications. http://www.kraiglabs.com/
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About our Biotech investor portal:
BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.
Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (eight hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
C Van Zant: 800-665-0411 - email@example.com
Source - Investorideas.com